Albalon

Eye Pain, Photophobia, Iritis + 21 more

Treatment

6 Active Studies for Albalon

What is Albalon

Naphazoline

The Generic name of this drug

Treatment Summary

Naphazoline is a medication used to reduce congestion in the eyes and nose. It works by tightening the blood vessels in the affected area and can be found in many over-the-counter eye drops and nasal sprays. Naphazoline was developed in 1942 and is still widely used today.

AK-Con

is the brand name

image of different drug pills on a surface

Albalon Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

AK-Con

Naphazoline

1974

43

Effectiveness

How Albalon Affects Patients

Naphazoline is a drug that works to reduce congestion in the nose or eyes. It does this by constricting the blood vessels in these areas.

How Albalon works in the body

Naphazoline is a medication that constricts blood vessels and reduces swelling. It does this by stimulating receptors on the walls of the blood vessels, which causes them to narrow. This medication also triggers the release of a chemical called norepinephrine, which has the same effect. When taken for a long period of time, the body can become used to this medication and a condition called rhinitis medicamentosa can occur when it is stopped.

When to interrupt dosage

The measure of Albalon is contingent upon the diagnosed malady, including Eye Pain, Sinusitis and tetracycline. The amount of dosage is contingent upon the strategy of delivery (e.g. Solution / drops or Liquid - Ophthalmic) featured in the table beneath.

Condition

Dosage

Administration

Allergic Rhinitis

, 0.25 mg/mL, 0.2675 mg/mL, 0.00012 mg/mL, 0.12 mg/mL, 0.3 mg/mL, 0.1 mg/mL, 1.0 mg/mL, 0.5 mg/mL, 0.2 mg/mL, 0.00027 mL/mL, 0.01 mL/mL, 0.0125 mL/mL, 0.00015 mg/mL, 0.21 mL/mL, 0.0625 mL/mL, 0.0025 mg/mL, 0.012 %, 0.1 %, 1.0 mg, 0.051 %, 0.02675 %, 0.05 %, 0.025 %, 5.0 mg/mL, 0.03 %, 1.12 mg/mL, 0.00012 mg/mg, 0.00025 mg/mg, 0.27 mg/mL, 0.0625 mg/mL, 0.012 mg/mL, 0.01 %, 0.00376 mg/mg

, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Nasal, Liquid - Nasal, Spray - Nasal, Spray, Suspension / drops, Suspension / drops - Nasal, Topical, Solution / drops - Topical, Solution / drops - Nasal, Gel - Ophthalmic

Allergy to Tree Pollen

, 0.25 mg/mL, 0.2675 mg/mL, 0.00012 mg/mL, 0.12 mg/mL, 0.3 mg/mL, 0.1 mg/mL, 1.0 mg/mL, 0.5 mg/mL, 0.2 mg/mL, 0.00027 mL/mL, 0.01 mL/mL, 0.0125 mL/mL, 0.00015 mg/mL, 0.21 mL/mL, 0.0625 mL/mL, 0.0025 mg/mL, 0.012 %, 0.1 %, 1.0 mg, 0.051 %, 0.02675 %, 0.05 %, 0.025 %, 5.0 mg/mL, 0.03 %, 1.12 mg/mL, 0.00012 mg/mg, 0.00025 mg/mg, 0.27 mg/mL, 0.0625 mg/mL, 0.012 mg/mL, 0.01 %, 0.00376 mg/mg

, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Nasal, Liquid - Nasal, Spray - Nasal, Spray, Suspension / drops, Suspension / drops - Nasal, Topical, Solution / drops - Topical, Solution / drops - Nasal, Gel - Ophthalmic

tetracycline

, 0.25 mg/mL, 0.2675 mg/mL, 0.00012 mg/mL, 0.12 mg/mL, 0.3 mg/mL, 0.1 mg/mL, 1.0 mg/mL, 0.5 mg/mL, 0.2 mg/mL, 0.00027 mL/mL, 0.01 mL/mL, 0.0125 mL/mL, 0.00015 mg/mL, 0.21 mL/mL, 0.0625 mL/mL, 0.0025 mg/mL, 0.012 %, 0.1 %, 1.0 mg, 0.051 %, 0.02675 %, 0.05 %, 0.025 %, 5.0 mg/mL, 0.03 %, 1.12 mg/mL, 0.00012 mg/mg, 0.00025 mg/mg, 0.27 mg/mL, 0.0625 mg/mL, 0.012 mg/mL, 0.01 %, 0.00376 mg/mg

, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Nasal, Liquid - Nasal, Spray - Nasal, Spray, Suspension / drops, Suspension / drops - Nasal, Topical, Solution / drops - Topical, Solution / drops - Nasal, Gel - Ophthalmic

Dermatitis

, 0.25 mg/mL, 0.2675 mg/mL, 0.00012 mg/mL, 0.12 mg/mL, 0.3 mg/mL, 0.1 mg/mL, 1.0 mg/mL, 0.5 mg/mL, 0.2 mg/mL, 0.00027 mL/mL, 0.01 mL/mL, 0.0125 mL/mL, 0.00015 mg/mL, 0.21 mL/mL, 0.0625 mL/mL, 0.0025 mg/mL, 0.012 %, 0.1 %, 1.0 mg, 0.051 %, 0.02675 %, 0.05 %, 0.025 %, 5.0 mg/mL, 0.03 %, 1.12 mg/mL, 0.00012 mg/mg, 0.00025 mg/mg, 0.27 mg/mL, 0.0625 mg/mL, 0.012 mg/mL, 0.01 %, 0.00376 mg/mg

, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Nasal, Liquid - Nasal, Spray - Nasal, Spray, Suspension / drops, Suspension / drops - Nasal, Topical, Solution / drops - Topical, Solution / drops - Nasal, Gel - Ophthalmic

Otitis

, 0.25 mg/mL, 0.2675 mg/mL, 0.00012 mg/mL, 0.12 mg/mL, 0.3 mg/mL, 0.1 mg/mL, 1.0 mg/mL, 0.5 mg/mL, 0.2 mg/mL, 0.00027 mL/mL, 0.01 mL/mL, 0.0125 mL/mL, 0.00015 mg/mL, 0.21 mL/mL, 0.0625 mL/mL, 0.0025 mg/mL, 0.012 %, 0.1 %, 1.0 mg, 0.051 %, 0.02675 %, 0.05 %, 0.025 %, 5.0 mg/mL, 0.03 %, 1.12 mg/mL, 0.00012 mg/mg, 0.00025 mg/mg, 0.27 mg/mL, 0.0625 mg/mL, 0.012 mg/mL, 0.01 %, 0.00376 mg/mg

, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Nasal, Liquid - Nasal, Spray - Nasal, Spray, Suspension / drops, Suspension / drops - Nasal, Topical, Solution / drops - Topical, Solution / drops - Nasal, Gel - Ophthalmic

Allergic Conjunctivitis (AC)

, 0.25 mg/mL, 0.2675 mg/mL, 0.00012 mg/mL, 0.12 mg/mL, 0.3 mg/mL, 0.1 mg/mL, 1.0 mg/mL, 0.5 mg/mL, 0.2 mg/mL, 0.00027 mL/mL, 0.01 mL/mL, 0.0125 mL/mL, 0.00015 mg/mL, 0.21 mL/mL, 0.0625 mL/mL, 0.0025 mg/mL, 0.012 %, 0.1 %, 1.0 mg, 0.051 %, 0.02675 %, 0.05 %, 0.025 %, 5.0 mg/mL, 0.03 %, 1.12 mg/mL, 0.00012 mg/mg, 0.00025 mg/mg, 0.27 mg/mL, 0.0625 mg/mL, 0.012 mg/mL, 0.01 %, 0.00376 mg/mg

, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Nasal, Liquid - Nasal, Spray - Nasal, Spray, Suspension / drops, Suspension / drops - Nasal, Topical, Solution / drops - Topical, Solution / drops - Nasal, Gel - Ophthalmic

Conjunctivitis

, 0.25 mg/mL, 0.2675 mg/mL, 0.00012 mg/mL, 0.12 mg/mL, 0.3 mg/mL, 0.1 mg/mL, 1.0 mg/mL, 0.5 mg/mL, 0.2 mg/mL, 0.00027 mL/mL, 0.01 mL/mL, 0.0125 mL/mL, 0.00015 mg/mL, 0.21 mL/mL, 0.0625 mL/mL, 0.0025 mg/mL, 0.012 %, 0.1 %, 1.0 mg, 0.051 %, 0.02675 %, 0.05 %, 0.025 %, 5.0 mg/mL, 0.03 %, 1.12 mg/mL, 0.00012 mg/mg, 0.00025 mg/mg, 0.27 mg/mL, 0.0625 mg/mL, 0.012 mg/mL, 0.01 %, 0.00376 mg/mg

, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Nasal, Liquid - Nasal, Spray - Nasal, Spray, Suspension / drops, Suspension / drops - Nasal, Topical, Solution / drops - Topical, Solution / drops - Nasal, Gel - Ophthalmic

Eye Pain

, 0.25 mg/mL, 0.2675 mg/mL, 0.00012 mg/mL, 0.12 mg/mL, 0.3 mg/mL, 0.1 mg/mL, 1.0 mg/mL, 0.5 mg/mL, 0.2 mg/mL, 0.00027 mL/mL, 0.01 mL/mL, 0.0125 mL/mL, 0.00015 mg/mL, 0.21 mL/mL, 0.0625 mL/mL, 0.0025 mg/mL, 0.012 %, 0.1 %, 1.0 mg, 0.051 %, 0.02675 %, 0.05 %, 0.025 %, 5.0 mg/mL, 0.03 %, 1.12 mg/mL, 0.00012 mg/mg, 0.00025 mg/mg, 0.27 mg/mL, 0.0625 mg/mL, 0.012 mg/mL, 0.01 %, 0.00376 mg/mg

, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Nasal, Liquid - Nasal, Spray - Nasal, Spray, Suspension / drops, Suspension / drops - Nasal, Topical, Solution / drops - Topical, Solution / drops - Nasal, Gel - Ophthalmic

Photophobia

, 0.25 mg/mL, 0.2675 mg/mL, 0.00012 mg/mL, 0.12 mg/mL, 0.3 mg/mL, 0.1 mg/mL, 1.0 mg/mL, 0.5 mg/mL, 0.2 mg/mL, 0.00027 mL/mL, 0.01 mL/mL, 0.0125 mL/mL, 0.00015 mg/mL, 0.21 mL/mL, 0.0625 mL/mL, 0.0025 mg/mL, 0.012 %, 0.1 %, 1.0 mg, 0.051 %, 0.02675 %, 0.05 %, 0.025 %, 5.0 mg/mL, 0.03 %, 1.12 mg/mL, 0.00012 mg/mg, 0.00025 mg/mg, 0.27 mg/mL, 0.0625 mg/mL, 0.012 mg/mL, 0.01 %, 0.00376 mg/mg

, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Nasal, Liquid - Nasal, Spray - Nasal, Spray, Suspension / drops, Suspension / drops - Nasal, Topical, Solution / drops - Topical, Solution / drops - Nasal, Gel - Ophthalmic

Iritis

, 0.25 mg/mL, 0.2675 mg/mL, 0.00012 mg/mL, 0.12 mg/mL, 0.3 mg/mL, 0.1 mg/mL, 1.0 mg/mL, 0.5 mg/mL, 0.2 mg/mL, 0.00027 mL/mL, 0.01 mL/mL, 0.0125 mL/mL, 0.00015 mg/mL, 0.21 mL/mL, 0.0625 mL/mL, 0.0025 mg/mL, 0.012 %, 0.1 %, 1.0 mg, 0.051 %, 0.02675 %, 0.05 %, 0.025 %, 5.0 mg/mL, 0.03 %, 1.12 mg/mL, 0.00012 mg/mg, 0.00025 mg/mg, 0.27 mg/mL, 0.0625 mg/mL, 0.012 mg/mL, 0.01 %, 0.00376 mg/mg

, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Nasal, Liquid - Nasal, Spray - Nasal, Spray, Suspension / drops, Suspension / drops - Nasal, Topical, Solution / drops - Topical, Solution / drops - Nasal, Gel - Ophthalmic

Dry Eye Syndromes

, 0.25 mg/mL, 0.2675 mg/mL, 0.00012 mg/mL, 0.12 mg/mL, 0.3 mg/mL, 0.1 mg/mL, 1.0 mg/mL, 0.5 mg/mL, 0.2 mg/mL, 0.00027 mL/mL, 0.01 mL/mL, 0.0125 mL/mL, 0.00015 mg/mL, 0.21 mL/mL, 0.0625 mL/mL, 0.0025 mg/mL, 0.012 %, 0.1 %, 1.0 mg, 0.051 %, 0.02675 %, 0.05 %, 0.025 %, 5.0 mg/mL, 0.03 %, 1.12 mg/mL, 0.00012 mg/mg, 0.00025 mg/mg, 0.27 mg/mL, 0.0625 mg/mL, 0.012 mg/mL, 0.01 %, 0.00376 mg/mg

, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Nasal, Liquid - Nasal, Spray - Nasal, Spray, Suspension / drops, Suspension / drops - Nasal, Topical, Solution / drops - Topical, Solution / drops - Nasal, Gel - Ophthalmic

Dacryocystitis

, 0.25 mg/mL, 0.2675 mg/mL, 0.00012 mg/mL, 0.12 mg/mL, 0.3 mg/mL, 0.1 mg/mL, 1.0 mg/mL, 0.5 mg/mL, 0.2 mg/mL, 0.00027 mL/mL, 0.01 mL/mL, 0.0125 mL/mL, 0.00015 mg/mL, 0.21 mL/mL, 0.0625 mL/mL, 0.0025 mg/mL, 0.012 %, 0.1 %, 1.0 mg, 0.051 %, 0.02675 %, 0.05 %, 0.025 %, 5.0 mg/mL, 0.03 %, 1.12 mg/mL, 0.00012 mg/mg, 0.00025 mg/mg, 0.27 mg/mL, 0.0625 mg/mL, 0.012 mg/mL, 0.01 %, 0.00376 mg/mg

, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Nasal, Liquid - Nasal, Spray - Nasal, Spray, Suspension / drops, Suspension / drops - Nasal, Topical, Solution / drops - Topical, Solution / drops - Nasal, Gel - Ophthalmic

Pink Eye

, 0.25 mg/mL, 0.2675 mg/mL, 0.00012 mg/mL, 0.12 mg/mL, 0.3 mg/mL, 0.1 mg/mL, 1.0 mg/mL, 0.5 mg/mL, 0.2 mg/mL, 0.00027 mL/mL, 0.01 mL/mL, 0.0125 mL/mL, 0.00015 mg/mL, 0.21 mL/mL, 0.0625 mL/mL, 0.0025 mg/mL, 0.012 %, 0.1 %, 1.0 mg, 0.051 %, 0.02675 %, 0.05 %, 0.025 %, 5.0 mg/mL, 0.03 %, 1.12 mg/mL, 0.00012 mg/mg, 0.00025 mg/mg, 0.27 mg/mL, 0.0625 mg/mL, 0.012 mg/mL, 0.01 %, 0.00376 mg/mg

, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Nasal, Liquid - Nasal, Spray - Nasal, Spray, Suspension / drops, Suspension / drops - Nasal, Topical, Solution / drops - Topical, Solution / drops - Nasal, Gel - Ophthalmic

Sinusitis

, 0.25 mg/mL, 0.2675 mg/mL, 0.00012 mg/mL, 0.12 mg/mL, 0.3 mg/mL, 0.1 mg/mL, 1.0 mg/mL, 0.5 mg/mL, 0.2 mg/mL, 0.00027 mL/mL, 0.01 mL/mL, 0.0125 mL/mL, 0.00015 mg/mL, 0.21 mL/mL, 0.0625 mL/mL, 0.0025 mg/mL, 0.012 %, 0.1 %, 1.0 mg, 0.051 %, 0.02675 %, 0.05 %, 0.025 %, 5.0 mg/mL, 0.03 %, 1.12 mg/mL, 0.00012 mg/mg, 0.00025 mg/mg, 0.27 mg/mL, 0.0625 mg/mL, 0.012 mg/mL, 0.01 %, 0.00376 mg/mg

, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Nasal, Liquid - Nasal, Spray - Nasal, Spray, Suspension / drops, Suspension / drops - Nasal, Topical, Solution / drops - Topical, Solution / drops - Nasal, Gel - Ophthalmic

Blepharoconjunctivitis

, 0.25 mg/mL, 0.2675 mg/mL, 0.00012 mg/mL, 0.12 mg/mL, 0.3 mg/mL, 0.1 mg/mL, 1.0 mg/mL, 0.5 mg/mL, 0.2 mg/mL, 0.00027 mL/mL, 0.01 mL/mL, 0.0125 mL/mL, 0.00015 mg/mL, 0.21 mL/mL, 0.0625 mL/mL, 0.0025 mg/mL, 0.012 %, 0.1 %, 1.0 mg, 0.051 %, 0.02675 %, 0.05 %, 0.025 %, 5.0 mg/mL, 0.03 %, 1.12 mg/mL, 0.00012 mg/mg, 0.00025 mg/mg, 0.27 mg/mL, 0.0625 mg/mL, 0.012 mg/mL, 0.01 %, 0.00376 mg/mg

, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Nasal, Liquid - Nasal, Spray - Nasal, Spray, Suspension / drops, Suspension / drops - Nasal, Topical, Solution / drops - Topical, Solution / drops - Nasal, Gel - Ophthalmic

Eye

, 0.25 mg/mL, 0.2675 mg/mL, 0.00012 mg/mL, 0.12 mg/mL, 0.3 mg/mL, 0.1 mg/mL, 1.0 mg/mL, 0.5 mg/mL, 0.2 mg/mL, 0.00027 mL/mL, 0.01 mL/mL, 0.0125 mL/mL, 0.00015 mg/mL, 0.21 mL/mL, 0.0625 mL/mL, 0.0025 mg/mL, 0.012 %, 0.1 %, 1.0 mg, 0.051 %, 0.02675 %, 0.05 %, 0.025 %, 5.0 mg/mL, 0.03 %, 1.12 mg/mL, 0.00012 mg/mg, 0.00025 mg/mg, 0.27 mg/mL, 0.0625 mg/mL, 0.012 mg/mL, 0.01 %, 0.00376 mg/mg

, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Nasal, Liquid - Nasal, Spray - Nasal, Spray, Suspension / drops, Suspension / drops - Nasal, Topical, Solution / drops - Topical, Solution / drops - Nasal, Gel - Ophthalmic

ocular bacterial infections

, 0.25 mg/mL, 0.2675 mg/mL, 0.00012 mg/mL, 0.12 mg/mL, 0.3 mg/mL, 0.1 mg/mL, 1.0 mg/mL, 0.5 mg/mL, 0.2 mg/mL, 0.00027 mL/mL, 0.01 mL/mL, 0.0125 mL/mL, 0.00015 mg/mL, 0.21 mL/mL, 0.0625 mL/mL, 0.0025 mg/mL, 0.012 %, 0.1 %, 1.0 mg, 0.051 %, 0.02675 %, 0.05 %, 0.025 %, 5.0 mg/mL, 0.03 %, 1.12 mg/mL, 0.00012 mg/mg, 0.00025 mg/mg, 0.27 mg/mL, 0.0625 mg/mL, 0.012 mg/mL, 0.01 %, 0.00376 mg/mg

, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Nasal, Liquid - Nasal, Spray - Nasal, Spray, Suspension / drops, Suspension / drops - Nasal, Topical, Solution / drops - Topical, Solution / drops - Nasal, Gel - Ophthalmic

ocular vasoconstriction therapy

, 0.25 mg/mL, 0.2675 mg/mL, 0.00012 mg/mL, 0.12 mg/mL, 0.3 mg/mL, 0.1 mg/mL, 1.0 mg/mL, 0.5 mg/mL, 0.2 mg/mL, 0.00027 mL/mL, 0.01 mL/mL, 0.0125 mL/mL, 0.00015 mg/mL, 0.21 mL/mL, 0.0625 mL/mL, 0.0025 mg/mL, 0.012 %, 0.1 %, 1.0 mg, 0.051 %, 0.02675 %, 0.05 %, 0.025 %, 5.0 mg/mL, 0.03 %, 1.12 mg/mL, 0.00012 mg/mg, 0.00025 mg/mg, 0.27 mg/mL, 0.0625 mg/mL, 0.012 mg/mL, 0.01 %, 0.00376 mg/mg

, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Nasal, Liquid - Nasal, Spray - Nasal, Spray, Suspension / drops, Suspension / drops - Nasal, Topical, Solution / drops - Topical, Solution / drops - Nasal, Gel - Ophthalmic

Conjunctivitis, Bacterial

, 0.25 mg/mL, 0.2675 mg/mL, 0.00012 mg/mL, 0.12 mg/mL, 0.3 mg/mL, 0.1 mg/mL, 1.0 mg/mL, 0.5 mg/mL, 0.2 mg/mL, 0.00027 mL/mL, 0.01 mL/mL, 0.0125 mL/mL, 0.00015 mg/mL, 0.21 mL/mL, 0.0625 mL/mL, 0.0025 mg/mL, 0.012 %, 0.1 %, 1.0 mg, 0.051 %, 0.02675 %, 0.05 %, 0.025 %, 5.0 mg/mL, 0.03 %, 1.12 mg/mL, 0.00012 mg/mg, 0.00025 mg/mg, 0.27 mg/mL, 0.0625 mg/mL, 0.012 mg/mL, 0.01 %, 0.00376 mg/mg

, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Nasal, Liquid - Nasal, Spray - Nasal, Spray, Suspension / drops, Suspension / drops - Nasal, Topical, Solution / drops - Topical, Solution / drops - Nasal, Gel - Ophthalmic

Conjunctivitis

, 0.25 mg/mL, 0.2675 mg/mL, 0.00012 mg/mL, 0.12 mg/mL, 0.3 mg/mL, 0.1 mg/mL, 1.0 mg/mL, 0.5 mg/mL, 0.2 mg/mL, 0.00027 mL/mL, 0.01 mL/mL, 0.0125 mL/mL, 0.00015 mg/mL, 0.21 mL/mL, 0.0625 mL/mL, 0.0025 mg/mL, 0.012 %, 0.1 %, 1.0 mg, 0.051 %, 0.02675 %, 0.05 %, 0.025 %, 5.0 mg/mL, 0.03 %, 1.12 mg/mL, 0.00012 mg/mg, 0.00025 mg/mg, 0.27 mg/mL, 0.0625 mg/mL, 0.012 mg/mL, 0.01 %, 0.00376 mg/mg

, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Nasal, Liquid - Nasal, Spray - Nasal, Spray, Suspension / drops, Suspension / drops - Nasal, Topical, Solution / drops - Topical, Solution / drops - Nasal, Gel - Ophthalmic

Warnings

Albalon has one counterindication, so it should not be administered if any of the situations in the below table are present.

Albalon Contraindications

Condition

Risk Level

Notes

Severe Hypersensitivity Reactions

Do Not Combine

Naphazoline may interact with Pulse Frequency

There are 20 known major drug interactions with Albalon.

Common Albalon Drug Interactions

Drug Name

Risk Level

Description

Iobenguane

Major

Naphazoline can cause a decrease in the absorption of Iobenguane resulting in a reduced serum concentration and potentially a decrease in efficacy.

2,5-Dimethoxy-4-ethylthioamphetamine

Minor

The risk or severity of hypertension can be increased when Naphazoline is combined with 2,5-Dimethoxy-4-ethylthioamphetamine.

5-methoxy-N,N-dimethyltryptamine

Minor

The risk or severity of hypertension can be increased when Naphazoline is combined with 5-methoxy-N,N-dimethyltryptamine.

Abediterol

Minor

The risk or severity of hypertension can be increased when Naphazoline is combined with Abediterol.

Aceclofenac

Minor

The risk or severity of hypertension can be increased when Naphazoline is combined with Aceclofenac.

Albalon Toxicity & Overdose Risk

Taking too much naphazoline can cause severe drowsiness, low body temperature, slow heart rate, and even death. These effects are especially dangerous in children under 6 years old. If someone uses naphazoline for a long time, they may experience a stuffy nose when they stop taking the drug. It is not known how safe naphazoline is for young children and elderly patients, and it is not known if it can affect pregnancy or fertility. Pregnant and breast-feeding women should be aware of the potential risks before taking naphazoline.

image of a doctor in a lab doing drug, clinical research

Albalon Novel Uses: Which Conditions Have a Clinical Trial Featuring Albalon?

57 active trials are ongoing to examine the potential of Albalon to alleviate Sinusitis, Dermatitis and Allergic Rhinitis.

Condition

Clinical Trials

Trial Phases

Conjunctivitis

0 Actively Recruiting

Photophobia

3 Actively Recruiting

Not Applicable

Sinusitis

2 Actively Recruiting

Not Applicable

Eye

0 Actively Recruiting

Dry Eye Syndromes

0 Actively Recruiting

Iritis

0 Actively Recruiting

Rhinitis, Allergic

0 Actively Recruiting

Lacrimal Duct Obstruction

0 Actively Recruiting

Eye Pain

0 Actively Recruiting

Conjunctivitis, Bacterial

0 Actively Recruiting

tetracycline

0 Actively Recruiting

Blepharoconjunctivitis

0 Actively Recruiting

ocular vasoconstriction therapy

0 Actively Recruiting

Allergic Conjunctivitis (AC)

0 Actively Recruiting

Pink Eye

0 Actively Recruiting

Otitis

0 Actively Recruiting

Dermatitis

0 Actively Recruiting

Dacryocystitis

0 Actively Recruiting

ocular bacterial infections

0 Actively Recruiting

Lacrimation

0 Actively Recruiting

Albalon Reviews: What are patients saying about Albalon?

5

Patient Review

5/21/2016

Albalon for Red Eyes

I really appreciate this treatment--it's helped me a lot. However, I now can't find anyone who sells it in Ontario!

5

Patient Review

8/19/2016

Albalon for Red Eyes

I've been using this for a few days now to help with the puffiness in my eyes. I'm hopeful it will continue to improve things.

5

Patient Review

7/17/2017

Albalon for Red Eyes

I've used Albalon for more than two decades now. It's the only brand I trust for my dry eyes. I often wake up with red eyes, but after using this product as directed (one drop in each eye), they're back to normal within minutes.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about albalon

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Should Albalon eye drops sting?

"Side effects of Albalon may include: burning or stinging of the eye, blurred vision, or watery eyes."

Answered by AI

What is Albalon used for?

"This medication is used to relieve eye irritation and congestion, as well as to treat allergic and inflammatory conditions of the eye."

Answered by AI

Is Opcon good for your eyes?

"If the liquid in your eye drop bottle has changed colors or there are particles in it, don't use it. Using contaminated eye drops can infect your eye, leading to serious vision problems. Instead, call your pharmacist for new medicine. If your symptoms don't improve after three days of treatment, stop using the medicine and call your doctor."

Answered by AI

What is naphazoline used to treat?

"This medication reduces redness by constricting blood vessels in the eye."

Answered by AI

Clinical Trials for Albalon

Have you considered Albalon clinical trials?

We made a collection of clinical trials featuring Albalon, we think they might fit your search criteria.
Go to Trials
Image of Vancouver General Hospital in Vancouver, Canada.

In-Clinic Endoscopic Polypectomy for Nasal Polyps

18+
All Sexes
Vancouver, Canada

Chronic rhinosinusitis, also called chronic sinusitis, is a very common life-long disease affecting over 5% of the Canadian population. Its symptoms, including daily facial pain and headache, an inability to breath through the nose and complete smell loss, regularly impair one's ability to work and to enjoy and participate in daily activities. The annual cost of chronic sinusitis to Canada is estimated at $1.3 billion while the government pays an estimated $860 million yearly for chronic sinusitis treatment. Chronic sinusitis with polyps, the most common type of chronic sinusitis, is usually treated with a combination of medications and surgery. Until now, surgical treatment has only been performed in the operating room, at a cost of about $3500 per procedure. But, recent studies have shown that a new procedure, "in-clinic polyp removal", can provide an improvement in patient symptoms to levels equal to those for sinus surgery performed in a hospital operating room. Moreover, in clinic polyp removal has additional advantages including a shorter procedure recovery time, a significantly lower cost to the health care system (about one-tenth the cost or $450), and a shorter wait time for treatment. With the proposed pragmatic trial, the investigators will determine whether the in clinic polyp removal procedure is as good as sinus surgery in the operating room at controlling patient symptoms of chronic sinusitis. The investigators will also determine the cost and health-benefits for a patient, the healthcare system and for society of in clinic polyp removal in comparison to sinus surgery done in a hospital operating room. The investigators will then know if this new treatment, in clinic polyp removal, can replace sinus surgery as the standard of care for these patients.

Recruiting
Has No Placebo

Vancouver General Hospital (+4 Sites)

Shaun Kilty, MD

Medtronic